Your browser doesn't support javascript.
loading
Can metformin improve 'the tomorrow' of patients treated for oesophageal cancer?
Van De Voorde, L; Janssen, L; Larue, R; Houben, R; Buijsen, J; Sosef, M; Vanneste, B; Schraepen, M-C; Berbée, M; Lambin, P.
Afiliação
  • Van De Voorde L; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre +, Maastricht, The Netherlands. Electronic address: Lien.vandevoorde@maastro.nl.
  • Janssen L; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre +, Maastricht, The Netherlands.
  • Larue R; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre +, Maastricht, The Netherlands.
  • Houben R; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre +, Maastricht, The Netherlands.
  • Buijsen J; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre +, Maastricht, The Netherlands.
  • Sosef M; Department of Surgery, Atrium Medical Center, Heerlen, The Netherlands.
  • Vanneste B; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre +, Maastricht, The Netherlands.
  • Schraepen MC; Department of Surgery, Atrium Medical Center, Heerlen, The Netherlands.
  • Berbée M; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre +, Maastricht, The Netherlands.
  • Lambin P; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre +, Maastricht, The Netherlands.
Eur J Surg Oncol ; 41(10): 1333-9, 2015 Oct.
Article em En | MEDLINE | ID: mdl-26091848

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Diabetes Mellitus Tipo 2 / Hipoglicemiantes / Metformina Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged80 Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Diabetes Mellitus Tipo 2 / Hipoglicemiantes / Metformina Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged80 Idioma: En Ano de publicação: 2015 Tipo de documento: Article